RENAL CARE & DATA LINKAGE OF TASMANIAN KIDNEY DISEASE CASES
With
Professor Matthew Jose, Kidney Specialist
Head of Unit, Nephrology, Royal Hobart Hospital &
Professor of Medicine, University of Tasmania
Tasmania, Australia
RESEARCHER PROFILE
Filmed in Hobart, Tasmania, Australia | March 2026
Professor Matthew Jose is a Renal Physician & Head of the Renal Unit at the Royal Hobart Hospital, and Professor of Medicine for the University of Tasmania.
Winner of the 2021 Rural Science Award from the Australia and New Zealand Society of Nephrology, he has worked in regional, rural and remote Australian locations for nearly 20 years as a Renal Physician, including the Northern Territory.
He is currently Chairperson of the Tasmanian Statewide Kidney Clinical Network and a member of national clinical guideline groups including Therapeutic Guidelines and CARI guidelines kidney stone working group, as well as a member of the KidGEN (Kidney Genetics) national steering committee.
He has established the first regional young adult transplant clinic for young Tasmanians with a kidney transplant transferring from paediatric to adult care.
Professor Jose’s research has been funded by Australia’s NHMRC and MRFF, as well as Royal Hobart Hospital Research Foundation in Tasmania.
Source: Supplied and adapted
https://orcid.org/0000-0002-9589-0071
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
-
Genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia
Prof Deborah White’s research focus is genomics and rationally targeted therapies in Acute Lymphoblastic Leukaemia (ALL) and Chronic Myeloid Leukaemia (CML) and she holds peer reviewed grants from: The William Lawrence and Blanche Hughes Foundation and the Leukemia Lymphoma Society (USA), the NHMRC, the Leukaemia Foundation Australia (LFA), Channel 7, Cancer Australia, Tour de Cure and the Cancer Council SA (CCSA). Professor White has presented more than 170 papers at scientific meetings, and authored more than 100 scientific publications as well as being an inventor on several international patents.
-
DNA repair on the Fanconi anaemia pathway
Associate Professor Wayne Crismani is an internationally recognised expert in DNA repair, with a particular focus on Fanconi anaemia (FA)—a cancer-predisposition and bone marrow failure syndrome marked by extreme sensitivity to DNA damage. Based at St Vincent’s Institute in Melbourne, he leads a research program dedicated to understanding the genetic, cellular, and reproductive consequences of FA. He is currently supported by a Victorian Cancer Agency Mid-Career Fellowship and funding from the National Health and Medical Research Council.
